Monitoring T Cell Responses to Cancer Immunotherapy: Can We Now Identify Biomarkers Predicting Patients Who will be Responders

Publisher： Bentham Science Publishers

E-ISSN： 1875-6301|4|2|111-119

ISSN： 1573-3947

Source： Current Cancer Therapy Reviews, Vol.4, Iss.2, 2008-05, pp. : 111-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frequent T cell responses against immunogenic targets in lung cancer patients for targeted immunotherapy

By            

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 384-390

Spandidos Publications

Access to resources Recommend Favorite

Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

By Romero Pedro   Cerottini Jean-Charles   Speiser Daniel  

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 3, 2004-03 ,pp. : 249-255

Springer Publishing Company

Access to resources Recommend Favorite

NK Cell, Monocyte and Non T Cell Biomarkers as Prognostic Indicators in Cancer Immunotherapy

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 2, 2008-05 ,pp. : 120-124

Bentham Science Publishers

Access to resources Recommend Favorite

Small-cell lung cancer: where are we now and what can we expect for the future?

By Karachaliou Niki   Rosell Rafael  

Future Oncology, Vol. 9, Iss. 8, 2013-08 ,pp. : 1065-1068

Future Medicine

Access to resources Recommend Favorite

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

By  

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite